Australia markets closed

Zelira Therapeutics Limited (ZLD.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
1.0000+0.0300 (+3.09%)
At close: 03:51PM AEST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2021
30/06/2020
30/06/2019
Total revenue
1,070
432.568
-
-
Cost of revenue
-
228.222
-
-
Gross profit
207.267
204.346
-
-
Operating expenses
Research development
-
2,081
-
-
Selling general and administrative
4,979
4,490
1,974
1,253
Total operating expenses
10,567
10,196
7,937
4,238
Operating income or loss
-10,360
-9,991
-7,937
-4,238
Interest expense
12.344
42.627
12.344
-
Total other income/expenses net
-160.315
1,484
925.491
580.442
Income before tax
-10,568
-8,549
-7,015
-3,568
Income tax expense
0
0
0
0
Income from continuing operations
-10,568
-8,549
-7,015
-3,568
Net income
-10,221
-8,549
-7,015
-3,568
Net income available to common shareholders
-10,221
-8,549
-7,015
-3,568
Basic EPS
-
-1.28
-1.45
-0.82
Diluted EPS
-
-1.28
-1.45
-0.82
Basic average shares
-
6,633
4,848
4,314
Diluted average shares
-
6,633
4,848
4,314
EBITDA
-
-8,032
-6,728
-4,238